The weekly litigation news digest is live. Subscribe now

IP Verse

Method And Compositions For Cellular Immunotherapy - EP3824905

The patent EP3824905 was granted to Fred Hutchinson Cancer Center on Jan 8, 2025. The application was filed on Aug 20, 2013 under application number EP20201497A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3824905

FRED HUTCHINSON CANCER CENTER
Application Number
EP20201497A
Filing Date
Aug 20, 2013
Status
Granted And Under Opposition
Dec 6, 2024
Publication Date
Jan 8, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BOULT WADE TENNANTOct 8, 2025BOULT WADE TENNANTADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO1991US08442
DESCRIPTIONWO1994US05601
DESCRIPTIONUS6040177
OPPOSITIONEP3824905
OPPOSITIONWO2011056894
OPPOSITIONWO2012079000
OPPOSITIONWO2014031687
OTHEREP1755674
OTHEREP2884999
OTHERUS2013055862
SEARCHWO02077029
SEARCHWO2012129514

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents